Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Anika Therapeutics granted 3,360 restricted stock units to a newly hired non-executive employee on June 1, 2026, as part of their employment compensation package. The RSUs will vest in three equal installments over three years, subject to continuous service.